Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Hospira, Inc.    

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensus 
Company
Hospira, Inc. provides injectable drugs and infusion technologies.Its offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services.The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL.  
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on HOSPIRA, INC.
2015 HOSPIRA : Announces First Installation of Plum 360™ Infusion System With H..
2015 HOSPIRA : Announces First Installation of Plum 360(TM) Infusion System With Hosp..
2015DJPFIZER : Buy of Hospira Gets Green Light
2015DJPFIZER : Gets U.S. Approval to Acquire Hospira, With Divestitures
2015 HOSPIRA : Expert committee BACKS Hospira’s InflectraTM
2015 HOSPIRA : Charleston Area Medical Center Integrates Smart Pump Technology to Adv..
2015 HOSPIRA : TGA Approves First mAb Biosimilar
2015 HOSPIRA : Applauds UK's NICE for Issuing Adoption Resource to Help Drive the Int..
2015DJPFIZER : Gets EU Green Light for Hospira Merger
2015 HOSPIRA : Pfizer wins EU approval for $15 billion Hospira buy
More news
Sector news : Generic Pharmaceuticals
04:55a MYLAN : Investors call on Mylan chairman, director to step down
06/28 UK blue chips led lower by Hargreaves as strong pound takes toll
06/28DJVECTURA : In Asthma Collaboration With Novartis's Sandoz
06/28DJGLAXOSMITHKLINE : Announces US Filing For Mepolizumab
06/28DJMERCK AND : Today's Top Supply Chain and Logistics News From WSJ
More sector news : Generic Pharmaceuticals
4-Traders Strategies on HOSPIRA, INC. 
2013End of the technical recovery
More Strategies
News from SeekingAlpha
05/19 Upcoming Events - Panel For Epogen Biosimilar And Ocaliva's Lipid Test For Na..
2016 ABBOTT : Current Uncertainties Offer A Buying Opportunity
2016 New Management At ICU Medical Has Produced Positive Results
2016 PFIZER : 30%+ Discount With 4% Yield
2015 PREMARKET BIOTECH DIGEST : Trouble For Anticoagulants, Gilead U.S. Hep C Sales
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
F. Michael Ball Chief Executive Officer & Director
John C. Staley Non-Executive Chairman
Thomas E. Werner Chief Financial Officer & Senior Vice President
Sumant Ramachandra Chief Scientific Officer & Senior Vice President
Irving W. Bailey Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HOSPIRA, INC.0
OTSUKA HOLDINGS CO LTD-5.42%24 296
SUN PHARMACEUTICAL IND..-13.41%20 230
ONO PHARMACEUTICAL CO...-3.34%13 202
SHANGHAI FOSUN PHARMAC..35.05%11 127
ASPEN PHARMACARE HOLDI..0.37%9 873
More Results